Hedieh Sattarifard
@hedisattarifard.bsky.social
Epigenetics researcher, University of Calgary 🇨🇦🧬🥼
Pinned
Doxorubicin, a DNA intercalator, inhibits transcription elongation
Doxorubicin is a chemotherapeutic drug for cancer that intercalates into nucleosome-free regions at promoters. Doxorubicin was reported to result in loss of histone H3 trimethylated lysine 4 (H3K4me3)...
cdnsciencepub.com
Excited to share our latest publication, "Doxorubicin, a DNA intercalator, inhibits transcription elongation." This study explores how doxorubicin impacts gene regulation by interfering with transcription elongation.
Check it out!
cdnsciencepub.com/doi/10.1139/...
Check it out!
cdnsciencepub.com/doi/10.1139/...
Reposted by Hedieh Sattarifard
Registration is now OPEN for the 11th Canadian Conference on Epigenetics!
The annual meeting will be held November 12-15, 2025 at the Banff Centre in Banff, Alberta.
You can register and find out more information at our website: event.fourwaves.com/ceehrc2025
The annual meeting will be held November 12-15, 2025 at the Banff Centre in Banff, Alberta.
You can register and find out more information at our website: event.fourwaves.com/ceehrc2025
June 26, 2025 at 2:42 PM
Registration is now OPEN for the 11th Canadian Conference on Epigenetics!
The annual meeting will be held November 12-15, 2025 at the Banff Centre in Banff, Alberta.
You can register and find out more information at our website: event.fourwaves.com/ceehrc2025
The annual meeting will be held November 12-15, 2025 at the Banff Centre in Banff, Alberta.
You can register and find out more information at our website: event.fourwaves.com/ceehrc2025
Excited to share our latest publication, "Doxorubicin, a DNA intercalator, inhibits transcription elongation." This study explores how doxorubicin impacts gene regulation by interfering with transcription elongation.
Check it out!
cdnsciencepub.com/doi/10.1139/...
Check it out!
cdnsciencepub.com/doi/10.1139/...
Doxorubicin, a DNA intercalator, inhibits transcription elongation
Doxorubicin is a chemotherapeutic drug for cancer that intercalates into nucleosome-free regions at promoters. Doxorubicin was reported to result in loss of histone H3 trimethylated lysine 4 (H3K4me3)...
cdnsciencepub.com
February 16, 2025 at 3:06 AM
Excited to share our latest publication, "Doxorubicin, a DNA intercalator, inhibits transcription elongation." This study explores how doxorubicin impacts gene regulation by interfering with transcription elongation.
Check it out!
cdnsciencepub.com/doi/10.1139/...
Check it out!
cdnsciencepub.com/doi/10.1139/...